Literature DB >> 11897116

The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.

Cathy Donaldson1, Peter Michael Boers, Karen Lisa Hoskin, Alessandro Stefano Zagami, Geoffrey Andrew Lambert.   

Abstract

The importance of 5-HT(1B) and 5-HT(1D) receptors in the actions of the anti-migraine drug naratriptan was investigated using the relatively selective 5-HT(1) receptor ligands SB224289 and BRL15572. Electrical stimulation of the superior sagittal sinus (SSS) in cats activated neurones in the trigeminal nucleus caudalis. Facial receptive fields (RF) were also electrically stimulated to activate the same neurones. Responses of these neurones to SSS stimulation were suppressed by iontophoretic application of naratriptan (5-50 nA). There were two distinct populations of neurones in the nucleus--those in deeper laminae in which the responses to SSS and RF stimulation were equally suppressed by naratriptan ('non-selective') and more superficial neurones in which only the SSS responses were suppressed by naratriptan ('selective'). Concurrent micro-iontophoretic application (50 nA) of the 5-HT(1D) antagonist BRL15572 antagonised the suppression by naratriptan of the response of 'selective' cells to SSS stimulation. Iontophoretic application of SB224289 (50 nA), a 5-HT(1B) antagonist, antagonised the suppression by naratriptan of responses of 'non-selective' cells to RF stimulation and, to a lesser extent, also antagonised the suppression of responses to SSS stimulation. Intravenous administration of SB224289 antagonised the suppression only of RF responses of "non-selective" neurons by naratriptan and intravenous administration of BRL15572 antagonised the suppression only of SSS responses of "selective" neurons by naratriptan. These results suggest that the response of nucleus caudalis neurons to stimulation of the sagittal sinus can be modulated by both 5-HT(1B) and 5-HT(1D) receptor activation, with the 5-HT(1D) receptors perhaps playing a greater role. The response to RF stimulation is more influenced by 5-HT(1B) receptor modulation with 5-HT(1D) receptors being less important. Therefore, this suggests that selective 5-HT(1D) agonists may be able to target the neuronal population, which is selectively involved in the transmission of dural inputs. We conclude that the central terminals of trigeminal primary afferent fibres contain 5-HT(1B) and 5-HT(1D) receptors. Primary afferents from the dura mater may predominantly express 5-HT(1D) receptors, while facial afferents may predominantly express 5-HT(1B) receptors. Activation of 5-HT(1D) receptors in particular may be important in the anti-migraine effect of naratriptan.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897116     DOI: 10.1016/s0028-3908(01)00190-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

Review 1.  Serotonergic agents in the management of cluster headache.

Authors:  Giorgio Lambru; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2011-04

2.  Role of 5-HT(1) receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn.

Authors:  Hyo-Jin Jeong; Vanessa A Mitchell; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Inflammation induces developmentally regulated sumatriptan inhibition of spinal synaptic transmission.

Authors:  Bryony L Winters; Hyo-Jin Jeong; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-07-08       Impact factor: 8.739

Review 4.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications.

Authors:  Carey D Balaban; Rolf G Jacob; Joseph M Furman
Journal:  Expert Rev Neurother       Date:  2011-03       Impact factor: 4.618

6.  The complex actions of sumatriptan on rat dural afferents.

Authors:  Andrea M Harriott; Nicole N Scheff; Michael S Gold
Journal:  Cephalalgia       Date:  2012-06-18       Impact factor: 6.292

Review 7.  Preclinical neuropharmacology of naratriptan.

Authors:  Geoffrey A Lambert
Journal:  CNS Drug Rev       Date:  2005

Review 8.  From Mechanism to Cure: Renewing the Goal to Eliminate the Disease of Pain.

Authors:  Theodore J Price; Michael S Gold
Journal:  Pain Med       Date:  2018-08-01       Impact factor: 3.750

9.  Rizatriptan reduces vestibular-induced motion sickness in migraineurs.

Authors:  Joseph M Furman; Dawn A Marcus; Carey D Balaban
Journal:  J Headache Pain       Date:  2010-09-23       Impact factor: 7.277

10.  Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey.

Authors:  Hyo-Jin Jeong; David Chenu; Emma E Johnson; Mark Connor; Christopher W Vaughan
Journal:  Mol Pain       Date:  2008-11-11       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.